11-65794127-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_004561.4(OVOL1):c.197G>A(p.Arg66Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000929 in 1,613,796 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_004561.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OVOL1 | NM_004561.4 | c.197G>A | p.Arg66Gln | missense_variant | 2/4 | ENST00000335987.8 | NP_004552.2 | |
LOC124902693 | XM_047427980.1 | c.*1162-1740C>T | intron_variant | XP_047283936.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OVOL1 | ENST00000335987.8 | c.197G>A | p.Arg66Gln | missense_variant | 2/4 | 1 | NM_004561.4 | ENSP00000337862.3 | ||
OVOL1 | ENST00000532448.1 | c.11G>A | p.Arg4Gln | missense_variant | 1/3 | 1 | ENSP00000434220.1 | |||
OVOL1 | ENST00000531907.1 | n.*32G>A | downstream_gene_variant | 4 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152190Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000239 AC: 6AN: 251302Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135850
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1461606Hom.: 0 Cov.: 33 AF XY: 0.00000550 AC XY: 4AN XY: 727112
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152190Hom.: 0 Cov.: 33 AF XY: 0.0000404 AC XY: 3AN XY: 74340
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 19, 2024 | The c.197G>A (p.R66Q) alteration is located in exon 2 (coding exon 2) of the OVOL1 gene. This alteration results from a G to A substitution at nucleotide position 197, causing the arginine (R) at amino acid position 66 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at